Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci

Dale J. Hedges, Kara L. Hamilton-Nelson, Stephanie J. Sacharow, Laura Nations, Gary W. Beecham, Zhanna M. Kozhekbaeva, Brittany L. Butler, Holly N. Cukier, Patrice L. Whitehead, Deqiong Ma, James M. Jaworski, Lubov Nathanson, Joycelyn M. Lee, Stephen L. Hauser, Jorge R. Oksenberg, Michael L. Cuccaro, Jonathan L. Haines, John R. Gilbert, Margaret A. Pericak-Vance

Research output: Contribution to journalArticlepeer-review

27 Scopus citations


Background: Autism spectrum disorders (ASD) represent a group of neurodevelopmental disorders characterized by a core set of social-communicative and behavioral impairments. Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the brain, acting primarily via the GABA receptors (GABR). Multiple lines of evidence, including altered GABA and GABA receptor expression in autistic patients, indicate that the GABAergic system may be involved in the etiology of autism. Methods. As copy number variations (CNVs), particularly rare and de novo CNVs, have now been implicated in ASD risk, we examined the GABA receptors and genes in related pathways for structural variation that may be associated with autism. We further extended our candidate gene set to include 19 genes and regions that had either been directly implicated in the autism literature or were directly related (via function or ancestry) to these primary candidates. For the high resolution CNV screen we employed custom-designed 244 k comparative genomic hybridization (CGH) arrays. Collectively, our probes spanned a total of 11 Mb of GABA-related and additional candidate regions with a density of approximately one probe every 200 nucleotides, allowing a theoretical resolution for detection of CNVs of approximately 1 kb or greater on average. One hundred and sixty-eight autism cases and 149 control individuals were screened for structural variants. Prioritized CNV events were confirmed using quantitative PCR, and confirmed loci were evaluated on an additional set of 170 cases and 170 control individuals that were not included in the original discovery set. Loci that remained interesting were subsequently screened via quantitative PCR on an additional set of 755 cases and 1,809 unaffected family members. Results: Results include rare deletions in autistic individuals at JAKMIP1, NRXN1, Neuroligin4Y, OXTR, and ABAT. Common insertion/deletion polymorphisms were detected at several loci, including GABBR2 and NRXN3. Overall, statistically significant enrichment in affected vs. unaffected individuals was observed for NRXN1 deletions. Conclusions: These results provide additional support for the role of rare structural variation in ASD.

Original languageEnglish (US)
Article number2
JournalMolecular Autism
Issue number1
StatePublished - 2012


  • CGH
  • CNV
  • GABA
  • NRXN1

ASJC Scopus subject areas

  • Psychiatry and Mental health
  • Developmental Neuroscience
  • Developmental Biology
  • Molecular Biology


Dive into the research topics of 'Evidence of novel fine-scale structural variation at autism spectrum disorder candidate loci'. Together they form a unique fingerprint.

Cite this